Clinical trial
A Randomized, Open-label, 2-period, Crossover, Pilot Food Effect Study of BMS-984923 in Healthy Older Adult Volunteers
NCT05817643 is registered in ClinicalTrials.gov with Allyx Therapeutics as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized, Open-label, 2-period, Crossover, Pilot Food Effect Study of BMS-984923 in Healthy Older Adult Volunteers
- Lead sponsor
- Allyx Therapeutics
- Phase
- Phase 1
- Overall status
- Unknown status
- Start date
- January 10, 2023
- Completion date
- November 15, 2024
- Enrollment
- 12 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.